Amphstar Pharmaceuticals, Inc. (AMPH): Officer exercised options on 9,787 shares
Rong Zhou, Officer at Amphstar Pharmaceuticals, Inc., reported an option exercise of 9,787 shares.
- 9,787
- Shares · @ $11.33
- Traded
- Dec 17, 2025
- Filed
- Dec 18, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Oct 21, 2025Company filing · Form 8-K · Material agreementSigned an important agreement
- Nov 3, 2025InsiderDirector sold ~$13K of AMPH shares in the open market
- Nov 6, 2025Company filing · Form 8-K · ResultsReported its results
- Nov 13, 2025InsiderDirector sold ~$442K of AMPH shares in the open market
- Nov 25, 2025InsiderDirector sold ~$113K of AMPH shares in the open market
- Dec 11, 2025InsiderDirector sold ~$45K of AMPH shares in the open market
- Dec 12, 2025InsiderDirector sold ~$63K of AMPH shares in the open market
- Dec 17, 2025InsiderOfficer sold ~$256K of AMPH shares in the open market
What came next
- Jan 6, 2026Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors
- Feb 26, 2026Company filing · Form 8-K · ResultsReported its results
- Mar 3, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Mar 3, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On March 3, 2026 (the “Effective Date”), Amphastar Pharmaceuticals, Inc. (“Amphastar” or, the “Company”), entered into executive employment agreements with each of Jacob Liawatidewi, the Company’s Executive Vice President of Corporate Administration Center, Secretary and a member of the board of directors (the “Liawatidewi Employment Agreement”) and Rong Zhou, the Company’s Senior Executive Vice President of…”
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Amphstar Pharmaceuticals, Inc.
For Amphstar Pharmaceuticals, Inc., OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AMPH page.
Other recent filings by Rong Zhou, SENIOR EVP, PRODUCTION CENTER
- SEC Form 4 at Amphstar Pharmaceuticals, Inc. (AMPH)Sep 17, 2026
- SEC Form 4 at Amphstar Pharmaceuticals, Inc. (AMPH)Sep 3, 2026
- SEC Form 4 at Amphstar Pharmaceuticals, Inc. (AMPH)Dec 18, 2025
- SEC Form 4 at Amphstar Pharmaceuticals, Inc. (AMPH)Dec 16, 2024
- SEC Form 4 at Amphstar Pharmaceuticals, Inc. (AMPH)Dec 16, 2024
The full history of Rong Zhou, SENIOR EVP, PRODUCTION CENTER is on the profile page.
How this filing works
Explore the data
Common questions
Which Amphstar Pharmaceuticals, Inc. (AMPH) insider traded, and how much?
Rong Zhou, Officer at Amphstar Pharmaceuticals, Inc., reported an option exercise of 9,787 shares. At $11.33.
When did it happen, and when was it made public?
Traded: Dec 17, 2025. Filed: Dec 18, 2025. That is 1 day between the two dates.
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Amphstar Pharmaceuticals, Inc. recently?
For Amphstar Pharmaceuticals, Inc., OQRO holds 9 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the AMPH page.
Does this mean AMPH stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Amphstar Pharmaceuticals, Inc.
- SEC Form 4Nov 18, 2026
- SEC Form 144Nov 16, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 4Nov 6, 2026
- SEC Form 144Nov 5, 2026
- SEC Form 144Nov 4, 2026
Everything OQRO holds on this company is on its AMPH page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data